CEBRX
Price
$9.82
Change
-$0.00 (-0.00%)
Updated
Aug 6 closing price
Net Assets
293.48M
MEDBX
Price
$12.38
Change
-$0.00 (-0.00%)
Updated
Aug 6 closing price
Net Assets
7.43B
Interact to see
Advertisement

CEBRX vs MEDBX

Header iconCEBRX vs MEDBX Comparison
Open Charts CEBRX vs MEDBXBanner chart's image
Columbia Emerging Markets Bond Inst2
Price$9.82
Change-$0.00 (-0.00%)
VolumeN/A
Net Assets293.48M
MFS Emerging Markets Debt B
Price$12.38
Change-$0.00 (-0.00%)
VolumeN/A
Net Assets7.43B
CEBRX vs MEDBX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
CEBRX vs. MEDBX commentary
Aug 07, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CEBRX is a Hold and MEDBX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
MEDBX has more cash in the bank: 7.43B vs. CEBRX (293M). CEBRX pays higher dividends than MEDBX: CEBRX (5.40) vs MEDBX (4.89). CEBRX was incepted earlier than MEDBX: CEBRX (13 years) vs MEDBX (23 years). MEDBX (1.82) is less costly to investors than CEBRX (0.75). MEDBX is a more actively managed with annual turnover of: 58.00 vs. CEBRX (41.00). CEBRX has a lower initial minimum investment than MEDBX: CEBRX (0) vs MEDBX (1000). CEBRX annual gain was more profitable for investors over the last year : 9.77 vs. MEDBX (7.88). CEBRX return over 5 years is better than : 8.80 vs. MEDBX (4.39).
CEBRXMEDBXCEBRX / MEDBX
Total Expense Ratio0.751.8141%
Annual Report Gross Expense Ratio0.751.8241%
Fund Existence13 years23 years-
Gain YTD7.0445.675124%
Front LoadN/AN/A-
Min. Initial Investment01000-
Min. Initial Investment IRAN/AN/A-
Net Assets293M7.43B4%
Annual Yield % from dividends5.404.89110%
Returns for 1 year9.777.88124%
Returns for 3 years25.5523.16110%
Returns for 5 years8.804.39200%
Returns for 10 years44.6730.58146%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
RLUSX17.440.13
+0.75%
Lazard US Equity Focus R6
GSAKX19.48N/A
N/A
Goldman Sachs International Eq Inc A
TADGX82.02N/A
N/A
T. Rowe Price Dividend Growth Advisor
SZCCX38.40N/A
N/A
DWS Small Cap Core C
LINVX22.75N/A
N/A
Lord Abbett International Opp R6